UGC approved journal IJNRD Research Journal


INTERNATIONAL JOURNAL OF NOVEL RESEARCH AND DEVELOPMENT (IJNRD)
An International Open Access Journal |   ISSN: 2456-4184 |  IMPACT FACTOR: 5.57

Call For Paper

Issue: August 2019

Volume 4 | Issue 8

Impact Factor: 5.57

Submit Paper Online

Click Here For more Details

For Authors

Forms / Download

Editorial Board

Subscribe IJNRD

Facts & Figure

Impact Factor : 5.57

Issue per Year : 12

Volume Published : 4

Issue Published : 39

Article Submitted : 574

Article Published : 357

Total Authors : 930

Total Reviewer : 541

Total Pages : 79

Total Countries : 21

Visitor Counter


Indexing Partner

Published Paper Details
Paper Title: VON WILLEBRAND DISEASE: A BRIEF OVERVIEW
Authors Name: Kiran B. Kotade , Neha S. Golesar , Sachin B.Somwanshi , Ramdas T. Dolas
Author Reg. ID:
IJNRD_170038
Published Paper Id: IJNRD1705018
Published In: Volume 2 Issue 5, May-2017
Abstract: Von Willebrand Disease is a common inherited bleeding disorder characterized by excessive bleeding caused by a deficiency or abnormality of Von Willebrand Factor (VWF). VWF is a multimeric adhesive protein produced mainly by the endothelial cells. Characteristic bleeding symptoms include epitaxis, easy bruishing, oral cavity bleeding, and menorrhagia, bleeding after dental extraction, surgery and childbirth. In severe cases bleeding into joints and soft tissues may occur. There are three subtypes: type 1 and 3 represents quantitative variants and type 2 is group of four qualitative variants(type2A, 2B, 2M, 2N).The diagnosis of von willebrand disease requires specialized assays of von willebrand factor and/or molecular genetic testing of von willebrand factor. Severe bleeding episodes can be prevented or controlled with intravenous infusions of virally inactivated plasma derived clotting factor concentrates containing both von willebrand factor and factor VIII. Depending on the type of von willebrand disease, mild bleeding episodes usually respond to intravenous or subcutaneous treatment with desmopressin a vasopressin analogue. Other treatments that can reduce symptoms include fibrinolytic inhibitors and hormones for menorrhagia.
Keywords: Von Willebrand Disease (VWD), von Willebrand Factor (vWF), Bleeding.
Cite Article: "VON WILLEBRAND DISEASE: A BRIEF OVERVIEW", International Journal of Novel Research and Development (www.ijnrd.org), ISSN:2456-4184, Vol.2, Issue 5, page no.81-86, May-2017, Available :http://www.ijnrd.org/papers/IJNRD1705018.pdf
Downloads: 000381
Share Article:

Click Here to Download This Article

Article Preview

ISSN Details

DOI (A digital object identifier)



Providing A digital object identifier by DOI

RMS

Conference Proposal

Latest News / Updates

Open Access License Policy

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License

Creative Commons License This material is Open Knowledge This material is Open Data This material is Open Content

Important Details

Social Media

IJNRD